This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches
This meeting will focus on Tumor profiling (WG3). It will include a Management Committee meeting. Therefore, official MC members will be compulsory invited following COST regulations.
Wednesday, 28 October 2020
Prof. Leila Ammar-Keskes, TRANSCOLONCAN participant from Tunisia, will coordinate the project entitled "Towards a North-African Consortium of the Human Microbiome (NACHM) through strengthening the Capacities in Microbiome Analysis for Human Diseases at University of Sfax"